News Column

AVANIR PHARMACEUTICALS, INC. FILES (8-K) Disclosing Results of Operations and Financial Condition, Financial Statements and Exhibits

February 5, 2014

Item 2.02. Results of Operations and Financial Condition. On February 5, 2014 , Avanir Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the three months ended December 31, 2013 (the "Earnings Press Release"). A copy of the Earnings Press Release is furnished herewith as Exhibit 99.1. The information set forth under Item 2.02 and in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Earnings Press Release, dated February 5, 2014 -2- --------------------------------------------------------------------------------

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools